Navigation Links
Pharmion Corporation to Announce Third Quarter 2007 Financial Results
Date:10/18/2007

BOULDER, Colo., Oct. 18 /PRNewswire-FirstCall/ -- Pharmion Corporation (Nasdaq: PHRM) will announce its third quarter 2007 financial results on Wednesday, October 31, 2007, after the close of the U.S. financial markets. Pharmion's senior management will host a conference call and live audio webcast to discuss the company's results in greater detail shortly thereafter, at 5:00 p.m. ET on Wednesday, October 31, 2007.

This call is being webcast by Thomson /CCBN and can be accessed at Pharmion's website at http://www.pharmion.com. Dial-in numbers for the conference call are as follows: participants from the U.S. 800.260.8140, participants from Europe 617.614.3672, passcode: 60001162.

The webcast is also being distributed over Thomson/CCBN's Investor Distribution Network to both institutional and individual investors. Individual investors can listen to the call through Thomson/CCBN's individual investor center at http://www.fulldisclosure.com or by visiting any of the investor sites in Thomson/CCBN's Individual Investor Network. Institutional investors can access the call via Thomson/CCBN's password-protected event management site, Street Events (http://www.streetevents.com).

Pharmion is a leading global oncology company focused on acquiring, developing and commercializing innovative products for the treatment of hematology and oncology patients in the U.S., Europe and additional international markets. Pharmion has a number of products on the market including the world's first approved epigenetic drug, Vidaza(R), a DNA demethylating agent. Fo
'/>"/>

SOURCE Pharmion Corporation
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2

Related biology technology :

1. Trouble-shooting: Misincorporation or low fidelity
2. Roche Diagnostics Corporation
3. Roche Diagnostics Corporation
4. Promega Corporation: Wisconsins quiet innovator
5. Giuliani will keynote RedPrairie Corporations user conference
6. Madison Development Corporation makes loans to three area companies
7. Corporations and blogging
8. Metavante acquires Florida banking corporation
9. TriMas Corporations Cequent Group Acquires Chem-Chrome, Inc.
10. Speaker announces business members of IT Task Force
11. Doyle announces technology tax credits for Berbee
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/11/2014)... July 11, 2014  Researchers have pioneered a ... The new technology, called Virtual Finger, allows scientists ... like neurons and synapses using the flat surface ... makes 3D imaging studies orders of magnitude more ... unprecedented level across many areas of experimental biology. ...
(Date:7/10/2014)... 10, 2014 Understanding the need for ... lines, and the gap that currently exists in this ... its industry-leading portfolio of validated ion channel and GPCR ... cell lines, as ion channels control many critical physiological ... activity creates the potential to treat a variety of ...
(Date:7/10/2014)... 2014 EvoDerma ’s NOOME Anti-Aging Motion ... device now comes with a second treatment cup to help ... The new cup is thinner on the edges for a ... rough, thin and uneven surfaces on the face, neck and ... stimulating treatment on areas such as the cheeks and neck, ...
(Date:7/10/2014)... Utah , July 10, 2014 /PRNewswire-iReach/ ... annotation and interpretation, today announced an agreement ... (NGS) analytics for Lineagen,s NextStep Dx ... of neurodevelopmental and neurological disorders, currently offers ... microarray (CMA) testing service used by healthcare ...
Breaking Biology Technology:Virtual Finger Enables Scientists To Navigate And Analyze 3D Images Of Complex Biological Structures 2Virtual Finger Enables Scientists To Navigate And Analyze 3D Images Of Complex Biological Structures 3Leader in Ion Channel Research Announces Newly Validated and Re-Engineered Cells 2Leader in Ion Channel Research Announces Newly Validated and Re-Engineered Cells 3Introducing a New Bonus Treatment Cup for EvoDerma’s NOOME Anti-Aging Motion 2Tute Genomics Platform Selected to Provide Clinical Interpretation for Lineagen's NextStepDx PLUS Next-Generation Sequencing-Based Diagnostic Test 2Tute Genomics Platform Selected to Provide Clinical Interpretation for Lineagen's NextStepDx PLUS Next-Generation Sequencing-Based Diagnostic Test 3Tute Genomics Platform Selected to Provide Clinical Interpretation for Lineagen's NextStepDx PLUS Next-Generation Sequencing-Based Diagnostic Test 4
... Quantitative Research ... Worldwide, NEW YORK, ... of those fielded in the US and abroad -- were,conducted online last ... report, released today, indicates that Internet-based market,research -- once the orphan of ...
... Inc.,(Scimitar) issues a review of Neurobiological Technologies, Inc. ... at One Stroke,Drug at a Time; Each One ... our website: http://www.scimitarequity.com ., Neurobiological Technologies, ... business of acquiring and developing central nervous system,related ...
... Mark Ahn Brings ZyGEM Extensive Expertise in Developing and ... Commercializing Novel Clinical Products--, SOLANA BEACH, ... unique and innovative enzymatic solutions for DNA,extraction and detection and ... Ahn, Ph.D., as Chair of its newly,formed Clinical Advisory Board. ...
Cached Biology Technology:Technology Transforms Market Research in Pharmaceutical Industry 2Technology Transforms Market Research in Pharmaceutical Industry 3Neurobiological Technologies, Inc. (Nasdaq: NTII) Q2/08 Review Issued By Scimitar Equity Research, Inc. 2ZyGEM Appoints Leading Biotechnology Expert to Head Clinical Advisory Board 2ZyGEM Appoints Leading Biotechnology Expert to Head Clinical Advisory Board 3
(Date:7/10/2014)... organization of the International Science and Business Belt project ... researchers, led by professor Won Do Heo, have developed ... can remotely control specific receptors by light. They have ... with neuronal differentiation inducement. , The most significant feature ... to activate neuronal functions without the need of other ...
(Date:7/10/2014)... even improve the state of fisheries resources in ... Mediterranean has deteriorated over the past 20 years. ... reported in the Cell Press journal Current ... stringent monitoring of Mediterranean fishing activities, better enforcement ... Mediterranean waters. , Their data show that the ...
(Date:7/10/2014)... Institute for Interdisciplinary Research (MIIR) and the Marshall ... announced they will be partnering with an international ... Under the agreement with Shanghai-based HD Biosciences Co. ... and risks of discovery and development of these ... intellectual property and commercialization rights to products developed ...
Breaking Biology News(10 mins):New optogenetic tool for controlling neuronal signalling by blue light 2Mediterranean fish stocks show steady decline 2Marshall University to partner with international company in drug development venture 2
... (November 4, 2009) For more than 25 years, ... ( Strombus gigas ) have been unsuccessfuluntil now. For ... produce beaded (nucleated) and non-beaded cultured pearls from the ... Atlantic University,s Harbor Branch Oceanographic Institute (HBOI). With less ...
... vegetables is a new, patented technology in which a low-energy ... information on produce, thereby eliminating the need for common sticker-type ... variety of fruits and vegetables and is being used in ... been approved in Asia, South Africa, Central and South America, ...
... Researchers from the UCLA Henry Samueli School of ... successfully reconstituted in the laboratory the enzyme responsible for ... The research, published Oct. 23 in the journal ... of other compounds with similarly beneficial effects. ...
Cached Biology News:Scientists are first to 'unlock' the mystery of creating cultured pearls from the queen conch 2Scientists are first to 'unlock' the mystery of creating cultured pearls from the queen conch 3Laser etching safe alternative for labeling grapefruit 2UCLA researchers reconstitute enzyme that synthesizes cholesterol drug lovastatin 2
Cross reactivity to St. Louis encephalitis (MSI-7) is determined by ELISA....
RABBIT ANTI HUMAN ATR (aa2122-2380) Immunogen: Human ATR peptide, amino acids 2122-2380...
RABBIT ANTI D-TYROSINE CONJUGATE...
UV LAMP 300 NM 8W T5, 1 EA. Category: Nucleid Acid Detection Systems....
Biology Products: